We found that tumor volumes and weights of both A549-shPCK2 and H1975-shPCK2 were significantly decreased compared to those of control cells, indicating the critical role of PCK2 in the growth of NSCLC cells in vivo (Figures 5A–F). This evidence concerns the gene PCK2 and neoplasm.